Free Trial

SunOpta (NASDAQ:STKL) Stock Price Up 13.3% on Better-Than-Expected Earnings

SunOpta logo with Consumer Staples background

Key Points

  • SunOpta's stock price surged by 13.3% after reporting better-than-expected earnings of $0.04 per share, exceeding analysts' predictions of $0.02.
  • The company generated revenue of $191.49 million for the quarter, surpassing the consensus estimate of $185.36 million.
  • Insider transactions indicated confidence in the company, with CEO Brian W. Kocher purchasing 10,000 shares at an average price of $5.72.
  • Need Better Tools to Track SunOpta? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

SunOpta, Inc. (NASDAQ:STKL - Get Free Report) TSE: SOY's share price rose 13.3% during mid-day trading on Thursday following a better than expected earnings announcement. The company traded as high as $6.30 and last traded at $5.88. Approximately 474,858 shares were traded during mid-day trading, a decline of 45% from the average daily volume of 871,071 shares. The stock had previously closed at $5.19.

The company reported $0.04 earnings per share for the quarter, topping analysts' consensus estimates of $0.02 by $0.02. SunOpta had a negative net margin of 1.90% and a positive return on equity of 11.65%. The company had revenue of $191.49 million during the quarter, compared to the consensus estimate of $185.36 million.

Insider Buying and Selling at SunOpta

In other SunOpta news, CEO Brian W. Kocher purchased 10,000 shares of the company's stock in a transaction that occurred on Tuesday, June 10th. The stock was acquired at an average cost of $5.72 per share, with a total value of $57,200.00. Following the completion of the purchase, the chief executive officer directly owned 10,000 shares in the company, valued at approximately $57,200. This represents a ∞ increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.90% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On SunOpta

A number of institutional investors and hedge funds have recently modified their holdings of the business. Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of SunOpta during the second quarter worth approximately $401,000. Fox Run Management L.L.C. bought a new stake in shares of SunOpta during the second quarter worth approximately $257,000. First Eagle Investment Management LLC raised its stake in shares of SunOpta by 37.8% during the second quarter. First Eagle Investment Management LLC now owns 586,750 shares of the company's stock worth $3,403,000 after buying an additional 160,824 shares during the last quarter. Bank of Montreal Can bought a new stake in shares of SunOpta during the second quarter worth approximately $68,000. Finally, Savvy Advisors Inc. bought a new stake in shares of SunOpta during the second quarter worth approximately $89,000. 85.39% of the stock is owned by institutional investors.

SunOpta Stock Performance

The company has a debt-to-equity ratio of 1.50, a current ratio of 0.95 and a quick ratio of 0.43. The firm has a market capitalization of $698.19 million, a P/E ratio of -46.00 and a beta of 1.32. The stock's 50 day moving average is $6.06 and its two-hundred day moving average is $5.85.

SunOpta Company Profile

(Get Free Report)

SunOpta Inc engages in manufacture and sale of plant-based and fruit-based food and beverage products in the United States, Canada, and internationally. The company provides plant-based beverages utilizing oat, almond, soy, coconut, rice, hemp, and other bases under the Dream and West Life brands; oat-based creamers under the SOWN brand; ready-to-drink protein shakes; and nut, grain, seed, and legume based beverages; packaged teas and concentrates; and meat and vegetable broths and stocks.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in SunOpta Right Now?

Before you consider SunOpta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SunOpta wasn't on the list.

While SunOpta currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without
Palantir & AMD Earnings: Massive Options Setups Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines